| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/14/2006 | US7011854 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 03/14/2006 | US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route |
| 03/14/2006 | CA2375430C C-pyrazole a2a receptor agonists |
| 03/14/2006 | CA2312935C Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/14/2006 | CA2165800C Antiallergic imidazoazepines |
| 03/14/2006 | CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
| 03/09/2006 | WO2006025583A1 External preparation of s/o type |
| 03/09/2006 | WO2006025345A1 Antihuman baff antibody |
| 03/09/2006 | WO2006025286A1 Constitutional function-improving agents |
| 03/09/2006 | WO2006024958A2 Cannabinoid compositions and methods of use thereof |
| 03/09/2006 | WO2006024930A1 Novel co-crystals between polyethylene glycols and 5-phenylpyrazolyl-1-benzenesulfonamides |
| 03/09/2006 | WO2006024776A1 N(1 h-indolyl)-1 h-indole-2-carb0xamide derivatives, their preparation and their therapeutic use |
| 03/09/2006 | WO2006024699A1 Thioxothiazolidinone compounds for use as pharmaceuticals |
| 03/09/2006 | WO2006024236A1 Medicine having analgesic effects |
| 03/09/2006 | WO2006004924A3 Imidazolo-related compounds, compositions and methods for their use |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052451 Method |
| 03/09/2006 | US20060052433 Compound |
| 03/09/2006 | US20060052419 Use of pyridly amides as inhibitors of angiogenesis |
| 03/09/2006 | US20060052415 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052389 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/09/2006 | US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 03/09/2006 | US20060052352 Mixtures or organic compounds for the treatment of airway diseases |
| 03/09/2006 | US20060052332 1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-carboxamides; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052313 Selective dipeptide inhibitors of kallikrein |
| 03/09/2006 | US20060052294 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051438 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 03/09/2006 | US20060051375 Rabbit skin comprising biological active substances and its use |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051343 Preventives remedies for bone and joint diseases |
| 03/09/2006 | DE102004043802A1 Mouth and dental care- and cleaning agent, useful for inflammatory diseases of the mouth and oral cavity e.g. gingivitis, comprises humectant and a protein of leguminous seeds e.g. protein of soy seeds |
| 03/09/2006 | CA2577222A1 Isoindoline compounds and methods of making and using the same |
| 03/09/2006 | CA2576924A1 Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| 03/09/2006 | CA2576830A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use |
| 03/09/2006 | CA2576727A1 N(1 h-indolyl)-1 h-indole-2-carb0xamide derivatives, their preparation and their therapeutic use |
| 03/08/2006 | EP1632489A1 5-(1,1'-Biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use. |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1632235A2 Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders |
| 03/08/2006 | EP1632234A2 (S,S)-reboxetine for treating chronic fatigue syndrome |
| 03/08/2006 | EP1632226A1 Anti-inflammatory analgesic adhesive patch |
| 03/08/2006 | EP1632224A1 Spill resistant pharmaceutical compositions |
| 03/08/2006 | EP1631592A2 Molecules for targeting and releasing therapeutic compounds, and the use thereof |
| 03/08/2006 | EP1631567A2 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 03/08/2006 | EP1631562A1 Chromene derivatives as anti-inflammatory agents |
| 03/08/2006 | EP1631559A2 Il-8 receptor antagonists |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1556397B1 9a-azalides with anti-inflammatory activity |
| 03/08/2006 | EP1494703B1 Chemokines mutants having improved oral bioavailability |
| 03/08/2006 | EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1448592B1 Steroidal compounds for inhibiting steroid sulphatase |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1438341B1 Antibody stimulating il-1ra production |
| 03/08/2006 | EP1429689A4 Rational drug therapy device and methods |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1363895B1 Process for the production of tocotrienols |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1347743B1 Composition for treatment of inflammatory disorders |
| 03/08/2006 | EP1346221B1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1326589B1 Nanoparticles |
| 03/08/2006 | EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 03/08/2006 | EP1276722B1 Naphthamidine urokinase inhibitors |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 03/08/2006 | EP1150704B1 Melagatran for the treatment of inflammation |
| 03/08/2006 | EP1079806B1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |
| 03/08/2006 | EP1039902B1 Inhibitors of gap junction communication |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP1005460B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 03/08/2006 | EP0800532B1 Improved cyclic crf agonists |
| 03/08/2006 | CN1745098A Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1745069A Mercaptoimidazoles as CCR2 receptor antagonists |
| 03/08/2006 | CN1744920A Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 03/08/2006 | CN1744910A Drugs containing galectin 9 |
| 03/08/2006 | CN1744897A Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 03/08/2006 | CN1742997A Mimetics of interleukin-8 and use of them in the prevention, treatment, diagnosis of a disease |
| 03/08/2006 | CN1742995A Zuanshanfeng guttage pill and preparing method |
| 03/08/2006 | CN1742972A External-use medicine of Herba chloranthi multistachydis |
| 03/08/2006 | CN1742969A Pandanguo medicated liquor |
| 03/08/2006 | CN1742965A Fracture medicated liquor of mappianthus iodordes |
| 03/08/2006 | CN1742961A External-use medicine of Rhizome cyperi |
| 03/08/2006 | CN1742959A Health-care medicated pad |
| 03/08/2006 | CN1742946A Fracture medicated liquor made from Folium nerviliae cum cormo |
| 03/08/2006 | CN1742945A Liangwang-tea fracture medicated liquor |
| 03/08/2006 | CN1742944A Chinese-yeast-hops medicated liquor |
| 03/08/2006 | CN1742932A Fracture medicated liquor of sargentaglory vine |
| 03/08/2006 | CN1742930A Copper battledore medicated liquor |